Fig. 1From: Detailed statistical analysis plan for the SafeBoosC III trial: a multinational randomised clinical trial assessing treatment guided by cerebral oxygenation monitoring versus treatment as usual in extremely preterm infantsTrial flow diagram. BPD bronchopulmonary dysplasia, NEC necrotising enterocolitis, NICU neonatal intensive care unit, ROP retinopathy of prematurityBack to article page